Dong H. Sinn

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 306 publications

Carvedilol versus Propranolol in Patients with Hepatocellular Carcinoma: A Nationwide Cohort Study.

Carvedilol versus Propranolol in Patients with Hepatocellular Carcinoma: A Nationwide Cohort Study.

Journal: Liver cancer

Published: May 18, 2026

Non-Selective Beta-Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation.

Non-Selective Beta-Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation.

Journal: Alimentary pharmacology & therapeutics

Published: May 11, 2026

KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).

KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA).

Journal: Clinical and molecular hepatology

Published: May 09, 2026

Risk-stratified MRI surveillance for hepatocellular carcinoma in cirrhosis: a prospective cohort study.

Risk-stratified MRI surveillance for hepatocellular carcinoma in cirrhosis: a prospective cohort study.

Journal: European radiology

Published: April 03, 2026

Systemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapy.

Systemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapy.

Journal: Journal of liver cancer

Published: February 18, 2026

Aggressive Histologic Subtypes Drive Poor Outcomes after Percutaneous Ablation for Early Recurrent Hepatocellular Carcinoma.

Aggressive Histologic Subtypes Drive Poor Outcomes after Percutaneous Ablation for Early Recurrent Hepatocellular Carcinoma.

Journal: Journal of vascular and interventional radiology : JVIR

Published: February 10, 2026

Aging-related skeletal muscle loss on the incidence of chronic kidney disease in patients with metabolic dysfunction-associated steatotic liver disease.

Aging-related skeletal muscle loss on the incidence of chronic kidney disease in patients with metabolic dysfunction-associated steatotic liver disease.

Journal: The journal of nutrition, health & aging

Published: January 18, 2026

Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approach.

Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approach.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 12, 2026

Metabolic Dysfunction-Associated Fibrosis 5 Score and the Risk of Liver-Related Events in the General Population.

Metabolic Dysfunction-Associated Fibrosis 5 Score and the Risk of Liver-Related Events in the General Population.

Journal: Gut and liver

Published: December 23, 2025

E-cigarette switching, smoking cessation, and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nationwide cohort study in South Korea.

E-cigarette switching, smoking cessation, and the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A nationwide cohort study in South Korea.

Journal: Preventive medicine

Published: December 21, 2025

Physical Activity Improves Overall Survival in Patients with Hepatocellular Carcinoma.

Physical Activity Improves Overall Survival in Patients with Hepatocellular Carcinoma.

Journal: Liver cancer

Published: December 15, 2025

Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis.

Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis.

Journal: Annals of hepatology

Published: November 15, 2025

Showing 1-12 of 306

Last Updated: 09/26/2026